Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia.
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia. Leukemia. 2021 05; 35(5):1267-1278.
View in:
PubMed
subject areas
Antineoplastic Agents
B-Lymphocytes
Casein Kinase II
Cell Line
Cell Line, Tumor
Child
Gene Expression Regulation, Leukemic
Genes, Tumor Suppressor
HEK293 Cells
Humans
Naphthyridines
Phenazines
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Signal Transduction
TOR Serine-Threonine Kinases
authors with profiles
Kim J. Payne